Inhibition of exercise-induced asthma by oral procaterol, a new beta 2-adrenergic drug.
8 asthmatics were studied for 2 consecutive days in order to assess the preventive effect of a new oral beta 2-sympathomimetic, procaterol hydrochloride, against exercise-induced asthma. Statistical analysis of the resulting data showed that this preparation, unlike other oral beta 2-sympathomimetics, affords good protection against exercise-induced asthma.